Mar. 11 at 6:54 PM
$INMB $INMB The "Librarian" shorts just got hit with a Sovereign Reality Check. 🥊
While retail was sleeping, Lucid Capital Markets just slapped a
$9.00 PRICE TARGET on this monster. They finally realized what we already knew: XPro™ isn't just a drug—it’s the Neuro-Protection Standard. 🧠🛡️
The Actuality:
✅
$9.00 PRICE TARGET — Lucid confirms we are 84.3% UNDERVALUED right now.
✅ CORDStrom™ ALPHA — RDEB pipeline is a multi-billion dollar sleeper.
✅ EARNINGS CATALYST (MARCH 26) — The April
$2.00 Calls are officially Gamma Magnets. 🧲
✅ PHASE 2 REGISTRATION — FDA alignment has slashed the regulatory floor.
The 19.6% short float is officially Combustible Liquidity. We are coiling for the April God-Candle that resets the entire sector. 🕯️✨
$1.41 is the Launchpad.
$4.00 is the Floor.
$9.00 is the Extraction.
THE DATA IS THE PROOF. THE CONTRACTS ARE THE PAYDAY. THE BABY WINS. 🚀📈🍼
#AlzheimersCure #ShortSqueeze #INMB #BioTechAlpha #VictoryForTheBaby #GapFill #LucidUpgrade
